Adaptimmune Competitors and Similar CompaniesClear all

Adaptimmune's competitors and similar companies include Bellicum Pharmaceuticals and PolyPid.

	Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.	Bellicum Pharmaceuticals Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.	PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API).
Founding Date	Founding Date 2008	Founding Date 2004	Founding Date 2008
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare Technology biotech healthtech pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare Technology biotech healthtech pharma
Locations	Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB	Locations Houston, US HQ Houston, US Houston, US South San Francisco, US	Locations Petah Tikva, IL HQ Summit, US
Employees	Employees 4007% decrease	Employees 1386% increase	Employees 57
Valuation ($)	Valuation ($) 188.5 m	Valuation ($) 778.3 k	Valuation ($) 23.7 m
Financial
Revenue (est.)	Revenue (est.) $178m (FY, 2024)	Revenue (est.) $1.5m (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods $70k (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $178m (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income ($70.8m) (FY, 2024)	Net income ($25m) (FY, 2022)	Net income ($34.2m) (FY, 2025)
Operating ⚠
Patent Applications	Patent Applications 69 (FY, 2016)	Patent Applications N/A	Patent Applications 49 (FY, 2017)
Patents Issued	Patents Issued 173 (FY, 2016)	Patents Issued N/A	Patents Issued 104 (FY, 2017)
Funding
Total funding raised	Total funding raised $ 107.5m	Total funding raised N/A	Total funding raised $ 103.8m